A multilevel analysis of patient engagement and patient-reported outcomes in primary care practices of accountable care organizations SM Shortell, BY Poon, PP Ramsay, HP Rodriguez, SL Ivey, T Huber, ... Journal of general internal medicine 32, 640-647, 2017 | 108 | 2017 |
An arterial based complexity (ABC) scoring system to assess the morbidity profile of partial nephrectomy M Spaliviero, BY Poon, CA Karlo, GB Guglielmetti, PL Di Paolo, ... European urology 69 (1), 72-79, 2016 | 108 | 2016 |
Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder M Spaliviero, G Dalbagni, BH Bochner, BY Poon, H Huang, ... The Journal of urology 192 (3), 702-707, 2014 | 78 | 2014 |
Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer MJ Zelefsky, BY Poon, J Eastham, A Vickers, X Pei, PT Scardino Radiotherapy and Oncology 118 (1), 85-91, 2016 | 67 | 2016 |
Interobserver variability of RENAL, PADUA, and centrality index nephrometry score systems M Spaliviero, BY Poon, O Aras, PL Di Paolo, GB Guglielmetti, ... World journal of urology 33, 853-858, 2015 | 67 | 2015 |
Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening EA Vertosick, BY Poon, AJ Vickers The Journal of urology 192 (3), 724-729, 2014 | 46 | 2014 |
Patient activation as a pathway to shared decision-making for adults with diabetes or cardiovascular disease BY Poon, SM Shortell, HP Rodriguez Journal of general internal medicine 35, 732-742, 2020 | 39 | 2020 |
Twenty-year risk of prostate cancer death by midlife prostate-specific antigen and a panel of four kallikrein markers in a large population-based cohort of healthy men DD Sjoberg, AJ Vickers, M Assel, A Dahlin, BY Poon, D Ulmert, H Lilja European urology 73 (6), 941-948, 2018 | 37 | 2018 |
Prostate size and adverse pathologic features in men undergoing radical prostatectomy SK Hong, BY Poon, DD Sjoberg, PT Scardino, JA Eastham Urology 84 (1), 153-157, 2014 | 35 | 2014 |
Can confirmatory biopsy be omitted in patients with prostate cancer favorable diagnostic features on active surveillance? P Satasivam, BY Poon, B Ehdaie, AJ Vickers, JA Eastham The Journal of urology 195 (1), 74-79, 2016 | 34 | 2016 |
Linking practice adoption of patient engagement strategies and relational coordination to patient‐reported outcomes in accountable care organizations HP Rodriguez, BY Poon, E Wang, SM Shortell The Milbank Quarterly 97 (3), 692-735, 2019 | 25 | 2019 |
Anthropometric measures at multiple times throughout life and prostate cancer diagnosis, metastasis, and death A Gerdtsson, JB Poon, DL Thorek, LA Mucci, MJ Evans, P Scardino, ... European urology 68 (6), 1076-1082, 2015 | 17 | 2015 |
Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed G leason score 3+ 4 prostate cancer T Gondo, BY Poon, K Matsumoto, M Bernstein, DD Sjoberg, JA Eastham BJU international 115 (1), 81-86, 2015 | 14 | 2015 |
Variation in serum prostate‐specific antigen levels in men with prostate cancer managed with active surveillance B Ehdaie, BY Poon, DD Sjoberg, P Recabal, V Laudone, K Touijer, ... BJU international 118 (4), 535-540, 2016 | 10 | 2016 |
Comparison of postradical cystectomy ileus rates using GIA-80 versus GIA-60 intestinal stapler device M Ghanaat, AG Winer, DD Sjoberg, BY Poon, M Kashan, AL Tin, ... Urology 122, 121-126, 2018 | 7 | 2018 |
Physician practice transitions to system ownership do not result in diminished practice responsiveness to patients BY Poon, S Shortell, HP Rodriguez Health services research 53 (4), 2268, 2018 | 7 | 2018 |
Concordance between patient-reported and physician-reported sexual function after radical prostatectomy AE Thong, BY Poon, JK Lee, E Vertosick, DD Sjoberg, AJ Vickers, ... Urologic Oncology: Seminars and Original Investigations 36 (2), 80. e1-80. e6, 2018 | 5 | 2018 |
Can confirmatory biopsy be omitted in prostate cancer active surveillance patients with favorable diagnostic features? P Satasivam, BY Poon, B Ehdaie, AJ Vickers, JA Eastham The Journal of urology 195 (1), 74, 2016 | 4 | 2016 |
Patient experience of interpersonal processes of care and subsequent utilization of hormone therapy for non-metastatic breast cancer BY Poon, CH Kroenke, GC Hillyer, LE Lamerato, AL Stewart, A Neugut, ... CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 30 (4), 806-807, 2021 | 1 | 2021 |
PD18-08 CAN MUSCLE− INVASIVE BLADDER CANCER BE PREDICTED IN PATIENTS WITH CLINICAL T1 DISEASE? I Sternberg, L Baldinger, R Mano, B Katz, BY Poon, H Herr, B Bochner, ... The Journal of Urology 191 (4S), e538-e538, 2014 | 1 | 2014 |